Micro Emerging Active

Climb Bio의 FDA Fast Track 지정

New narrative with limited coverage — still forming.

점수
0.5
모멘텀
▲ 1.0
기사
2
출처
1

Sentiment Timeline

Event Timeline

4월 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
4월 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

관련 기사

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · 4월 24, 2026
Mixed

타임라인

최종 업데이트4월 22, 2026